Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Tracking Results of Ablations to Combat AF Registry Generation 2

NCT: NCT05111015 · RECRUITING

NCT IDNCT05111015
StatusRECRUITING
Start Date2024-03-11
Completion2040-01
SponsorAtriCure, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.

Frequently Asked Questions

What is Tracking Results of Ablations to Combat AF Registry Generation 2?

Tracking Results of Ablations to Combat AF Registry Generation 2 is a clinical trial registered under NCT05111015. Current status: RECRUITING.

What is the status of NCT05111015?

The current status of NCT05111015 (Tracking Results of Ablations to Combat AF Registry Generation 2) is: RECRUITING.

When did Tracking Results of Ablations to Combat AF Registry Generation 2 start?

Tracking Results of Ablations to Combat AF Registry Generation 2 started on 2024-03-11.

Related Devices

K180137AtriCure cryoICE cryo-ablation probe (CRYO3), AtriCure cryoICE cryoFORM cryo-ablation probe (CRYOF)AtriCure, Inc. K180138AtriCure cryoICE cryo-ablation probe (CRYO2)AtriCure, Inc. K200697AtriCure cryoICE cryo-ablation probe (Cryo2), AAtriCure cryoICE cryoSPHERE cryoablation probe (CryoS, CryoS-L)AtriCure, Inc. K210477AtriCure Isolator Encompass Ablation System, GLIDEPATH Magnetic GUIDEAtriCure, Inc. K211311AtriCure Isolator® Synergy™ Surgical Ablation SystemAtriCure, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑